Correlation Between Acconeer and Moberg Pharma

Can any of the company-specific risk be diversified away by investing in both Acconeer and Moberg Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acconeer and Moberg Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Acconeer AB and Moberg Pharma AB, you can compare the effects of market volatilities on Acconeer and Moberg Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acconeer with a short position of Moberg Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acconeer and Moberg Pharma.

Diversification Opportunities for Acconeer and Moberg Pharma

0.7

Correlation Coefficient

Acconeer  Moberg Pharma

Poor diversification

The 3 months correlation between Acconeer and Moberg is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Acconeer AB and Moberg Pharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moberg Pharma AB and Acconeer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acconeer AB are associated (or correlated) with Moberg Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moberg Pharma AB has no effect on the direction of Acconeer i.e., Acconeer and Moberg Pharma go up and down completely randomly.

Pair Corralation between Acconeer and Moberg Pharma

Assuming the 90 days trading horizon Acconeer AB is expected to under-perform the Moberg Pharma. In addition to that, Acconeer is 1.22 times more volatile than Moberg Pharma AB. It trades about -0.01 of its total potential returns per unit of risk. Moberg Pharma AB is currently generating about 0.07 per unit of volatility. If you would invest  811.00  in Moberg Pharma AB on April 25, 2025 and sell it today you would earn a total of  75.00  from holding Moberg Pharma AB or generate 9.25% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Acconeer AB  vs.  Moberg Pharma AB

Acconeer AB

Risk-Adjusted Performance

Very Weak

Over the last 90 days Acconeer AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Acconeer is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Moberg Pharma AB

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Moberg Pharma AB are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain fundamental drivers, Moberg Pharma may actually be approaching a critical reversion point that can send shares even higher in August 2025.

Pair Trading with Acconeer and Moberg Pharma

The main advantage of trading using opposite Acconeer and Moberg Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acconeer position performs unexpectedly, Moberg Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moberg Pharma will offset losses from the drop in Moberg Pharma's long position.

The idea behind Acconeer AB and Moberg Pharma AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.